We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Lucira Health Inc | NASDAQ:LHDX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.4523 | 0.4451 | 0.448 | 0 | 01:00:00 |
The RSUs will vest over four years, with 25% of the underlying shares vesting on the one year anniversary of the applicable vesting commencement date and 1/16th of the underlying shares vesting quarterly thereafter, subject to the new employees’ continued service relationship with Lucira through the applicable vesting dates. The awards are subject to the terms and conditions of Lucira’s 2022 Inducement Plan and the terms and conditions of an applicable award agreement covering the grant.
About Lucira HealthLucira is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira’s testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable, and on-the-spot molecular test results anywhere and at any time. The Lucira™ Check-It COVID-19 Test Kit (OTC) and Lucira™ COVID-19 All-In-One Test Kit (Rx) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection. For more information, visit www.lucirahealth.com.
Investor ContactGreg ChodaczekInvestorrelations@lucirahealth.com332-895-3230
1 Year Lucira Health Chart |
1 Month Lucira Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions